A Cystic Fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective in newborns aged four weeks and above, new research suggests. A Cystic Fibrosis drug ...
Cystic fibrosis is a hereditary disease that so far has been incurable. Those affected have thick, viscous mucus secretions in their lungs, and lung function diminishes steadily over time. Today, ...
Children and young adults with cystic fibrosis, especially those with severe CFTR variants, who receive ivacaftor have ...
A major new study led by RCSI University of Medicine and Health Sciences and Children's Health Ireland (CHI) has been awarded funding of €5.6M to work with babies and children in Ireland and the UK ...
In the US, children with cystic fibrosis (CF) were significantly less likely to develop food allergies than children without CF. However, boys and children not receiving pancreatic enzyme replacement ...
Picture shows Paul McNally, Associate Professor of Paediatrics at RCSI and Consultant in Respiratory Medicine at Children’s Health Ireland (CHI) at the launch of a major new study that has been ...
When UNSW Associate Professor Shafagh Waters explains cystic fibrosis (CF) to the children she works with, she asks them to imagine what is happening inside their own bodies. "I tell them to picture ...
Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results